Similarly, ELAVL3 and KALRN CEs were significantly elevated in AD+LATE and LATE, with the strongest effects observed in AD+LATE (p = 1.6e−05 and p = 4.6e−10, respectively). This evidence concerns the gene ELAVL3 and Alzheimer disease.